世界のヒト正常免疫グロブリン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP04173)
◆英語タイトル:Global Human Normal Immunoglobulin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP04173
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月18日(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ヒト正常免疫グロブリンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト正常免疫グロブリンの種類別市場規模(B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他)、用途別市場規模(政府機関、民間部門、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):CSL Behring、CNBG、Kedrion、Grifols、Kamada、Biotest、Shanghai RAAS、Emergent (Cangene)、CBPO、Hualan Bio、Sichuan Yuanda Shuyang、ADMA Biologics
・地域別グローバル市場分析 2015年-2020年
・ヒト正常免疫グロブリンの北米市場(アメリカ、カナダ、メキシコ)
・ヒト正常免疫グロブリンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ヒト正常免疫グロブリンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ヒト正常免疫グロブリンの南米市場(ブラジル、アルゼンチン)
・ヒト正常免疫グロブリンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他
・用途別分析:政府機関、民間部門、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Human Normal Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Human Normal Immunoglobulin sales will be xx in 2020 from Human Normal Immunoglobulin million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Human Normal Immunoglobulin market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Human Normal Immunoglobulin industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Human Normal Immunoglobulin and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Human Normal Immunoglobulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Human Normal Immunoglobulin market has been segmented into
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others

By Application, Human Normal Immunoglobulin has been segmented into:
Government Institutions
Private Sector
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Normal Immunoglobulin market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Normal Immunoglobulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Normal Immunoglobulin market.

The report offers in-depth assessment of the growth and other aspects of the Human Normal Immunoglobulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Human Normal Immunoglobulin Market Share Analysis
Human Normal Immunoglobulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Normal Immunoglobulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Normal Immunoglobulin sales, revenue and market share for each player covered in this report.

The major players covered in Human Normal Immunoglobulin are:
CSL Behring
CNBG
Kedrion
Grifols
Kamada
Biotest
Shanghai RAAS
Emergent (Cangene)
CBPO
Hualan Bio
Sichuan Yuanda Shuyang
ADMA Biologics

Among other players domestic and global, Human Normal Immunoglobulin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Normal Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Normal Immunoglobulin, with price, sales, revenue and global market share of Human Normal Immunoglobulin in 2018 and 2019.
Chapter 3, the Human Normal Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Normal Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Normal Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Normal Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Human Normal Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Normal Immunoglobulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Normal Immunoglobulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Overview of Global Human Normal Immunoglobulin Market
1.4.1 Global Human Normal Immunoglobulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Human Normal Immunoglobulin Industry Impact
1.6.1 COVID-19 Potential Implications for the Human Normal Immunoglobulin
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Human Normal Immunoglobulin
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CSL Behring SWOT Analysis
2.1.4 CSL Behring Product and Services
2.1.5 CSL Behring Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CNBG
2.2.1 CNBG Details
2.2.2 CNBG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CNBG SWOT Analysis
2.2.4 CNBG Product and Services
2.2.5 CNBG Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kedrion
2.3.1 Kedrion Details
2.3.2 Kedrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Kedrion SWOT Analysis
2.3.4 Kedrion Product and Services
2.3.5 Kedrion Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Grifols SWOT Analysis
2.4.4 Grifols Product and Services
2.4.5 Grifols Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kamada
2.5.1 Kamada Details
2.5.2 Kamada Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kamada SWOT Analysis
2.5.4 Kamada Product and Services
2.5.5 Kamada Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biotest
2.6.1 Biotest Details
2.6.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biotest SWOT Analysis
2.6.4 Biotest Product and Services
2.6.5 Biotest Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shanghai RAAS SWOT Analysis
2.7.4 Shanghai RAAS Product and Services
2.7.5 Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Emergent (Cangene)
2.8.1 Emergent (Cangene) Details
2.8.2 Emergent (Cangene) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Emergent (Cangene) SWOT Analysis
2.8.4 Emergent (Cangene) Product and Services
2.8.5 Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 CBPO
2.9.1 CBPO Details
2.9.2 CBPO Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CBPO SWOT Analysis
2.9.4 CBPO Product and Services
2.9.5 CBPO Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hualan Bio
2.10.1 Hualan Bio Details
2.10.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hualan Bio SWOT Analysis
2.10.4 Hualan Bio Product and Services
2.10.5 Hualan Bio Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sichuan Yuanda Shuyang
2.11.1 Sichuan Yuanda Shuyang Details
2.11.2 Sichuan Yuanda Shuyang Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sichuan Yuanda Shuyang SWOT Analysis
2.11.4 Sichuan Yuanda Shuyang Product and Services
2.11.5 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 ADMA Biologics
2.12.1 ADMA Biologics Details
2.12.2 ADMA Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 ADMA Biologics SWOT Analysis
2.12.4 ADMA Biologics Product and Services
2.12.5 ADMA Biologics Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Normal Immunoglobulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Normal Immunoglobulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Normal Immunoglobulin Manufacturer Market Share in 2019
3.3.2 Top 6 Human Normal Immunoglobulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Normal Immunoglobulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Normal Immunoglobulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Normal Immunoglobulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.3 Europe Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.5 South America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
5.1.1 North America Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
5.2 United States Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5.3 Canada Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5.4 Mexico Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
6.1.1 Europe Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.3 UK Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.4 France Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.5 Russia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.6 Italy Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Normal Immunoglobulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Normal Immunoglobulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Normal Immunoglobulin Revenue and Market Share by Regions (2015-2020)
7.2 China Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.3 Japan Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.4 Korea Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.5 India Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.7 Australia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
8.1.1 South America Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
8.3 Argentina Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.3 Turkey Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.4 Egypt Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.5 South Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Normal Immunoglobulin Sales and Market Share by Type (2015-2020)
10.2 Global Human Normal Immunoglobulin Revenue and Market Share by Type (2015-2020)
10.3 Global Human Normal Immunoglobulin Price by Type (2015-2020)
11 Global Human Normal Immunoglobulin Market Segment by Application
11.1 Global Human Normal Immunoglobulin Sales Market Share by Application (2015-2020)
11.2 Global Human Normal Immunoglobulin Revenue Market Share by Application (2015-2020)
11.3 Global Human Normal Immunoglobulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Normal Immunoglobulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Normal Immunoglobulin Market Forecast by Regions (2021-2025)
12.2.1 North America Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.2 Europe Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.4 South America Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Normal Immunoglobulin Market Forecast (2021-2025)
12.3 Human Normal Immunoglobulin Market Forecast by Type (2021-2025)
12.3.1 Global Human Normal Immunoglobulin Sales Forecast by Type (2021-2025)
12.3.2 Global Human Normal Immunoglobulin Market Share Forecast by Type (2021-2025)
12.4 Human Normal Immunoglobulin Market Forecast by Application (2021-2025)
12.4.1 Global Human Normal Immunoglobulin Sales Forecast by Application (2021-2025)
12.4.2 Global Human Normal Immunoglobulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

CSL Behring、CNBG、Kedrion、Grifols、Kamada、Biotest、Shanghai RAAS、Emergent (Cangene)、CBPO、Hualan Bio、Sichuan Yuanda Shuyang、ADMA Biologics

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヒト正常免疫グロブリン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Human Normal Immunoglobulin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。